Coegin Pharma AB Namn-Aktier new o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

7.41%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.07 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.296 G0 Units
PRICE DETERMINATION TIME07/16/2026 / 05:17:24 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.2960.29
PREV. DAY'S PRICE0.29 (07/15)
CHANGE DAY BEFORE
+0.01
2.07 %
52 WEEK HIGH / LOW0.88 (09/17)0.216 (08/05)

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
-0.24-0.11-0.07--
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
7.493.7923.29--
PRICE - SALES RATIO
--1,398.18--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A3EJC5
ISIN
SE0020357754
SYMBOL
7Z6
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
COEGIN PHARMA AB
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
09:00:00 AM - 05:30:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
Performance
2.11 %
-9.38 %
-18.54 %
-20.77 %
7.41 %
--
-22.87 %
High0.300.330.390.410.88--0.41
Low0.280.270.270.270.22--0.27

Dividende

pro Aktie
COEGIN PHARMA AB does not deliver dividend information

Company profile

Coegin Pharma AB is a biotechnology company with projects in hair growth, skin pigmentation, myocardial infarction, leukemia. What the projects have in common is that they are based on validated technology platforms and collaborations with researchers and academics internationally. Coegin Pharma was founded in 2005 and is headquartered in Lund, Sweden.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.